Cargando…
Asymmetric Dimethylarginine Protects Neurons from Oxygen Glucose Deprivation Insult by Modulating Connexin-36 Expression
BACKGROUND: Asymmetric dimethylarginine (ADMA) is a nonselective nitric oxide synthase inhibitor. ADMA is thought to inhibit the production of nitric oxide (NO) by neurons after oxygen-glucose deprivation (OGD). The gap junction protein Connexin-36 (cx-36) is involved in the pathophysiology of strok...
Autores principales: | Fang, Kun, Chen, Shufen, Wang, Yi, Chen, Fangzhe, Cui, Mei, Dong, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279069/ https://www.ncbi.nlm.nih.gov/pubmed/35847590 http://dx.doi.org/10.1155/2022/5339361 |
Ejemplares similares
-
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017) -
Parkin Protects against Oxygen-Glucose Deprivation/Reperfusion Insult by Promoting Drp1 Degradation
por: Tang, Jiayu, et al.
Publicado: (2016) -
Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022) -
Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020) -
Evaluation of Connexin 43 Redistribution and Endocytosis in Astrocytes Subjected to Ischemia/Reperfusion or Oxygen-Glucose Deprivation and Reoxygenation
por: Xie, Hongyan, et al.
Publicado: (2017)